Fuda Cancer Hospital– Advanced Cancer Care

Fuda Cancer Hospital is an internationally recognised super-speciality cancer care institution known for its advanced minimally invasive and robotic cancer treatments. Headquartered in China, Fuda has earned a global reputation for offering innovative and research-driven oncology solutions for both early-stage and advanced cancers. The hospital is especially renowned for pioneering technologies such as Cryosurgery, Immunotherapy, NanoKnife therapy, Brachytherapy, and targeted cancer treatments, which provide new hope to patients seeking effective alternatives to conventional cancer therapies. Affiliated with Jinan University and the Chinese Academy of Sciences, Fuda Cancer Hospital has operated as a leading international cancer hospital since 2010. It is the only hospital in Asia using NanoKnife technology and continues to be recognised for its expertise in minimally invasive cancer procedures that focus on precision, faster recovery, and improved patient outcomes. The hospital features over 400 beds, including VIP suites, and employs more than 500 experienced medical professionals dedicated to personalised cancer care. Every year, thousands of international patients from over 100 countries travel to Fuda for treatment, making it one of the most trusted names in global oncology. Patients from South-East Asia, Europe, the Middle East, and India choose Fuda for its patient-focused approach, advanced technologies, and comprehensive treatment planning. Beyond treatment, the hospital also specialises in follow-up care, long-term monitoring, rehabilitation support, and palliative care services to ensure continuous assistance throughout the patient’s cancer journey. In India, Fuda Cancer Hospital operates official consultation and support centres in Mumbai and Noida through its trusted healthcare partner Rekosh Healthcare. These centres help Indian patients access expert consultations, medical report evaluations, personalised treatment planning, second opinions, and seamless coordination with Fuda’s oncology specialists in China. Patients can receive guidance regarding advanced treatment options, travel arrangements, and ongoing follow-up support without needing to navigate the international healthcare process alone. Rekosh Healthcare is a global medical assistance company dedicated to making world-class healthcare accessible and affordable. With years of experience in international medical tourism and patient coordination, Rekosh connects patients to leading hospitals across India, China, Singapore, Malaysia, Thailand, Germany, and Australia. Through its partnership with Fuda, Rekosh ensures that Indian cancer patients receive reliable support, transparent communication, and access to some of the most advanced cancer treatments available worldwide. With its strong commitment to innovation, compassionate patient care, and global medical excellence, Fuda Cancer Hospital continues to provide hope and advanced treatment solutions to cancer patients around the world.